DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2022 年 06 月 15 日 10:00 上午 - 2022 年 06 月 15 日 1:00 下午

(Eastern Standard Time)

R&D QA Comprehensive Quality Strategy: An Approach to Managing Quality Risks throughout the Drug Development Lifecycle

Instructors

Matt  Burtt, MBA

Matt Burtt, MBA

Director Clinical QA, AbbVie, United States

After completing a Biomedical Engineering undergraduate degree, I built upon my internship with Abbott (eventually AbbVie) in a 2 year rotational program with different assignments every six months across the business landscape. Since then I've been in the R&D Quality Assurance world, added an MBA and spent the last 6 years helping to build a "Program Management" team in GCP QA. We have aggressively sought opportunities to drive proactive QA in the Development / Clinical landscape via fully embracing the integrated Quality System approach. Our team members support all compounds/assets with a strategic Quality mindset. Critical thinking, Risk and Issue Management have led to successful submissions, inspections and approvals.

Arun  Mathew, MSc

Arun Mathew, MSc

Associate Director, Abbvie, United States

Business process owner for quality risk management in R&D(2.6yrs) Risk Management experience(19 yrs.) Medical devices experience (16yrs). Contributed and reviewed the book Foundations of Quality Risk Management.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。